Bebtelovimab appears reliable for COVID-19 during Omicron epoch
For high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infectious Diseases.
Sep 20, 2022
0
22